The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia
Abstract
The purpose of this study was to investigate the effect of adding sustained-release (SR) bupropion to cognitive behavioral therapy (CBT) on smoking behavior and stability of psychiatric symptoms in patients with schizophrenia. We conducted a 3-month, double-blind, placebo-controlled trial of bupropion SR, 150 mg/day, added to a concurrent CBT program with 3-month follow-up in 19 stable outpatients with schizophrenia who wanted to quit smoking. Eighteen subjects completed the trial. Bupropion treatment was associated with significantly greater reduction in smoking, as measured by self-report verified by expired-air carbon monoxide (6/9 subjects, 66%), than placebo (1/9 subjects, 11%) during the 3-month active treatment period and the 3-month follow-up period. One subject in the bupropion group (11%) and no subjects in the placebo group achieved sustained tobacco abstinence for the 6-month trial. Bupropion treatment was associated with improvement in negative symptoms and greater stability of psychotic and depressive symptoms, compared with placebo, during the quit attempt. Subjects in the bupropion group experienced significant weight loss, compared with those on placebo during the smoking cessation attempt. These data suggest that bupropion SR, 150 mg/day, combined with CBT, may facilitate smoking reduction in patients with schizophrenia while stabilizing psychiatric symptoms during a quit attempt.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as well as improve mood symptoms when combined with bupropion in psychiatric populations trying to quit smoking.71”
From Are smoking cessation treatments associated with suicidality risk? An overview (2016) · cites this paper as [71]
Citations
Cites
Actual causes of death in the United States
McGinnis, J. M. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510180077038 · Cited by 5,480
A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
Hurt, R. D., Sachs, D. P. L., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., Khayrallah, M. A., Schroeder, D. R., Glover, P. N., Sullivan, C. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710233371703 · Cited by 1,261
Prevalence of smoking among psychiatric outpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.8.993 · Cited by 1,058 · cited 2×
“7% of the general US adult population (CDC, 1997; de Leon et al., 1995; Goff, Henderson, & Amico, 1992; Hughes, 1986).”
InfluentialExcess mortality of schizophrenia: A meta-analysis
Brown, S. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.6.502 · Cited by 869 · cited 2×
“…patients with schizophrenia are less likely to receive adequate routine and preventive medical care (Goldman, 1999; Viewig, Levenson, Pandurangi, & Silverman, 1995), resulting in a significant public health problem for people with schizophrenia (Brown, 1997; Dalmau, Bergman, & Brismar, 1997).”
Normalization of auditory physiology by cigarette smoking in schizophrenic patients
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1856 · Cited by 679
Freedman, R., Hall, M., Adler, L. E., & Leonard, S. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(94)00252-x · Cited by 678
Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.9.1189 · Cited by 579 · cited 1×
“Among samples of patients with schizophrenia, 74–92% smoke cigarettes, compared with 24.7% of the general US adult population (CDC, 1997; de Leon et al., 1995; Goff, Henderson, & Amico, 1992; Hughes, 1986).”
InfluentialSelf-citationSchizophrenia and smoking: an epidemiological survey in a state hospital
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.453 · Cited by 418 · cited 2×
“Patients with schizophrenia also smoke more cigarettes per day (de Leon et al., 1995) and attain higher serum levels of cotinine, the primary metabolite of nicotine (Olincy, Young, & Freedman, 1997).”
InfluentialNicotine-Haloperidol Interactions and Cognitive Performance in Schizophrenics
Levin, E. (1996) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00018-8 · Cited by 342
Ziedonis, D. M., & George, T. P. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.2.247 · Cited by 278
Cited by
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
Buchanan, R. W., Kreyenbuhl, J., Kelly, D. L., Noel, J. M., Boggs, D. L., Fischer, B. A., Himelhoch, S., Fang, B., Peterson, E., Aquino, P. R., et al. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp116 · Cited by 907
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Co‐Morbidity of Smoking in Patients with Psychiatric and Substance Use Disorders
Kalman, D., Morissette, S. B., & George, T. P. (2005) · The American Journal on Addictions · doi:10.1080/10550490590924728 · Cited by 594
Antidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567
Goff, D. C., Sullivan, L. M., McEvoy, J. P., Meyer, J. M., Nasrallah, H. A., Daumit, G. L., Lamberti, S., D'Agostino, R. B., Stroup, T. S., Davis, S., et al. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.08.010 · Cited by 528
Self-citation
Metadata
- Authors
- Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C.
- Affiliations
- Harvard University (US)
- Corresponding author
- Evins, A. Eden
- Venue
- Nicotine & Tobacco Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-11-01
- Volume
- 3
- Issue
- 4
- Pages
- 397-403
- ISSN
- 1462-2203 (ISSN-L)
- 1469-994X
- OpenAlex
- W2062555412
- Cited by
- 191
- References
- 30
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2022: 4 · 2021: 8 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 4 · 2016: 3 · 2015: 12 · 2014: 6 · 2013: 2 · 2012: 16
- FWCI
- 6.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nicotine & Tobacco Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r03da012542-02)
- National Institute on Drug Abuse (R03 DA12542-01)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- bupropion, cognitive behavioral therapy, smoking cessation, schizophrenia, nicotine dependence, bupropion sustained release, negative symptoms, psychotic symptoms, depressive symptoms, weight loss, smoking abstinence
- MeSH terms
- Aged, Combined Modality Therapy, Delayed-Action Preparations, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Pilot Projects, Schizophrenia, Time Factors, Tobacco Use Disorder, Cognitive Behavioral Therapy, Smoking Cessation, Bupropion, Dopamine Uptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. https://app.cochat.ai/papers/10.1080/14622200110073920
- The paper
- Evins, A. E., Mays, V. K., Rigotti, N. A., Tisdale, T., Cather, C., & Goff, D. C. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine & Tobacco Research. https://doi.org/10.1080/14622200110073920
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.